Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN

Autor: Polman, Nicole J, Uijterwaal, Margot H, Witte, Birgit I, Berkhof, Johannes, van Kemenade, Folkert J, Spruijt, JWM, van Baal, W Marchien, Graziosi, Peppino G C M, van Dijken, Dorenda K E, Verheijen, René H M, Helmerhorst, Theo J M, Steenbergen, Renske D M, Heideman, Daniëlle A M, Ridder, Ruediger, Snijders, Peter J F, Meijer, Chris J L M

Publikováno v: International Journal of Cancer, 140(2), 423-430. Wiley-Liss Inc.
Polman, N J, Uijterwaal, M H, Witte, B I, Berkhof, J, van Kemenade, F J, Spruijt, JWM, van Baal, W M, Graziosi, P G C M, van Dijken, D K E, Verheijen, R H M, Helmerhorst, T J M, Steenbergen, R D M, Heideman, D A M, Ridder, R, Snijders, P J F & Meijer, C J L M 2017, ' Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN ', International Journal of Cancer, vol. 140, no. 2, pp. 423-430 . https://doi.org/10.1002/ijc.30449

Women treated for high-grade cervical intraepithelial neoplasia (CIN) are at risk of recurrent CIN Grade 2 or worse (rCIN2+). Currently, posttreatment monitoring is performed using cytology or cytology/high-risk (hr)HPV cotesting. This study aimed to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::44907aca49aa9dbcd76e45f3de706fbf
https://pure.eur.nl/en/publications/e8c9d82d-269a-4f8a-b1b8-da278b14c05f

Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions

Autor: Louwers, JA, Zaal, A, Kocken, Marielle, ter Harmsel, WA, Graziosi, GCM, Spruijt, JWM, Berkhof, J, Balas, C, Papagiannakis, E, Snijders, PJF, Meijer, CJLM, van Kemenade, Folkert, Verheijen, RHM

Publikováno v: Bjog-An International Journal of Obstetrics and Gynaecology, 118(3), 309-318. Wiley-Blackwell Publishing Ltd

Objective To validate the dynamic spectral imaging (DSI) colposcope's colour-coded map in discriminating high- from low-grade cervical lesions and non-neoplastic tissue. Design Prospective, comparative, multicentre clinical trial. Setting The colposc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::633a2530f7e1115c18efb58251787942
https://pure.eur.nl/en/publications/62713036-7683-4e35-9ba5-14629036767b

Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.

Autor: Uijterwaal MH; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; Department of Obstetrics and Gynecology, Flevo Hospital, Almere, The Netherlands. Electronic address: m.uijterwaal@vumc.nl., van Zummeren M; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: ma.vanzummeren@vumc.nl., Kocken M; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: m.kocken@vumc.nl., Luttmer R; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: r.luttmer1@vumc.nl., Berkhof J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: h.berkhof@vumc.nl., Witte BI; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: b.witte@vumc.nl., van Baal WM; Department of Obstetrics and Gynecology, Flevo Hospital, Almere, The Netherlands. Electronic address: mbaal@flevoziekenhuis.nl., Graziosi GCM; Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: p.graziosi@antoniusziekenhuis.nl., Verheijen RHM; Department of Gynecological Oncology, UMCU Utrecht Cancer Center, The Netherlands. Electronic address: r.verheijen@umcutrecht.nl., Helmerhorst TJM; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: t.helmerhorst@erasmusmc.nl., van Dijken DKE; Department of Obstetrics and Gynecology, Onze Lieve Vrouwen Gasthuis West, Amsterdam, The Netherlands. Electronic address: d.dijken@olvg.nl., Spruijt JWM; Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: jwm.spruijt@vumc.nl., van Kemenade FJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: f.vankemenade@erasmusmc.nl., Fransen-Daalmeijer N; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: d.vd.vegt@quicknet.nl., Bekker-Lettink M; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: M.Lettink@vumc.nl., Heideman DAM; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: dam.heideman@vumc.nl., Snijders PJF; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: pjf.snijders@vumc.nl., Steenbergen RDM; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: r.steenbergen@vumc.nl., Meijer CJLM; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: cjlm.meijer@vumc.nl.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2016 Oct; Vol. 143 (1), pp. 135-142. Date of Electronic Publication: 2016 Jul 16.